Literature DB >> 23673875

Correlation between pathology and neuromelanin MR imaging in Parkinson's disease and dementia with Lewy bodies.

Shinichiro Kitao1, Eiji Matsusue2, Shinya Fujii3, Fuminori Miyoshi3, Toshio Kaminou3, Shinsuke Kato4, Hisao Ito5, Toshihide Ogawa3.   

Abstract

INTRODUCTION: Direct correlation between neuropathological findings and postmortem neuromelanin MR imaging (NmMRI) was performed in the substantia nigra pars compacta (SNc) to clarify the pathological background of the signal changes in normal, Parkinson's disease (PD), and dementia with Lewy bodies (DLB) cases.
METHODS: NmMRI of 10 % formalin-fixed autopsied midbrains was performed in three cases (normal control, DLB, and PD) with a 3T imaging system, using a 3D gradient echo T1-weighted sequence with a magnetization transfer contrast pulse. Neuropathological examinations of the midbrains were performed, and the density of neuromelanin-positive neurons (number per square millimeter) was determined. The extent of iron deposition in the midbrain was also evaluated using ferritin immunohistochemistry. Furthermore, we directly correlated the contrast signal ratio in the SNc and the density of neuromelanin-containing neurons.
RESULTS: Diffuse hyperintense areas in the SNc reflected well-preserved neuromelanin-containing neurons in the normal control case, whereas an iso-intense area in the SNc showed severe loss of neuromelanin-containing neurons in the DLB and PD cases. Increased signal intensity in the SNc was apparently not influenced by iron deposition. Furthermore, a significant positive correlation between signal intensity and the density of neuromelanin-containing neurons was seen in the SNc.
CONCLUSION: Based on the direct correlation between postportem NmMRI and neuropathological findings, signal intensity in the SNc is closely related to the quantity of neuromelanin-containing neurons but is not influenced by iron deposition.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23673875     DOI: 10.1007/s00234-013-1199-9

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  18 in total

1.  T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content.

Authors:  J Vymazal; A Righini; R A Brooks; M Canesi; C Mariani; M Leonardi; G Pezzoli
Journal:  Radiology       Date:  1999-05       Impact factor: 11.105

2.  Measurements of T1 and T2 over time in formalin-fixed human whole-brain specimens.

Authors:  M Tovi; A Ericsson
Journal:  Acta Radiol       Date:  1992-09       Impact factor: 1.990

3.  T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease.

Authors:  Stefan T Schwarz; Timothy Rittman; Vamsi Gontu; Paul S Morgan; Nin Bajaj; Dorothee P Auer
Journal:  Mov Disord       Date:  2011-04-12       Impact factor: 10.338

4.  Visualization of neuromelanin in the Substantia nigra and locus ceruleus at 1.5T using a 3D-gradient echo sequence with magnetization transfer contrast.

Authors:  Toshiki Nakane; Takashi Nihashi; Hisashi Kawai; Shinji Naganawa
Journal:  Magn Reson Med Sci       Date:  2008       Impact factor: 2.471

5.  Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson's disease.

Authors:  Kenichi Kashihara; Takayoshi Shinya; Fumiyo Higaki
Journal:  J Clin Neurosci       Date:  2011-06-29       Impact factor: 1.961

6.  Sources of the increased longitudinal relaxation rates observed in melanotic melanoma. An in vitro study of synthetic melanins.

Authors:  W S Enochs; W B Hyslop; H F Bennett; R D Brown; S H Koenig; H M Swartz
Journal:  Invest Radiol       Date:  1989-10       Impact factor: 6.016

7.  Paramagnetic metal scavenging by melanin: MR imaging.

Authors:  W S Enochs; P Petherick; A Bogdanova; U Mohr; R Weissleder
Journal:  Radiology       Date:  1997-08       Impact factor: 11.105

8.  Reduction of neuromelanin-positive nigral volume in patients with MSA, PSP and CBD.

Authors:  Kenichi Kashihara; Takayoshi Shinya; Fumiyo Higaki
Journal:  Intern Med       Date:  2011-08-15       Impact factor: 1.271

9.  Curvilinear T1 hyperintense lesions representing cortical necrosis after cerebral infarction.

Authors:  Toshibumi Kinoshita; Toshihide Ogawa; Yasuji Yoshida; Hajime Tamura; Hirotsugu Kado; Toshio Okudera
Journal:  Neuroradiology       Date:  2005-07-19       Impact factor: 2.804

10.  On the origin and significance of neuromelanin.

Authors:  D G Graham
Journal:  Arch Pathol Lab Med       Date:  1979-07       Impact factor: 5.534

View more
  35 in total

1.  Correlation between neuromelanin-sensitive MR imaging and (123)I-FP-CIT SPECT in patients with parkinsonism.

Authors:  Keita Kuya; Yuki Shinohara; Fuminori Miyoshi; Shinya Fujii; Yoshio Tanabe; Toshihide Ogawa
Journal:  Neuroradiology       Date:  2016-01-16       Impact factor: 2.804

2.  In vivo detection of lateral-ventral tier nigral degeneration in Parkinson's disease.

Authors:  Daniel E Huddleston; Jason Langley; Jan Sedlacik; Kai Boelmans; Stewart A Factor; Xiaoping P Hu
Journal:  Hum Brain Mapp       Date:  2017-02-27       Impact factor: 5.038

3.  A novel computerized algorithm to detect microstructural brainstem pathology in Parkinson's disease using standard 3 Tesla MR imaging.

Authors:  Kai Boelmans; Lothar Spies; Jan Sedlacik; Jens Fiehler; Holger Jahn; Christian Gerloff; Alexander Münchau
Journal:  J Neurol       Date:  2014-07-26       Impact factor: 4.849

Review 4.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

5.  Quantifying changes in nigrosomes using quantitative susceptibility mapping and neuromelanin imaging for the diagnosis of early-stage Parkinson's disease.

Authors:  Hiroto Takahashi; Yoshiyuki Watanabe; Hisashi Tanaka; Masahito Mihara; Hideki Mochizuki; Tian Liu; Yi Wang; Noriyuki Tomiyama
Journal:  Br J Radiol       Date:  2018-05-17       Impact factor: 3.039

6.  A multicontrast approach for comprehensive imaging of substantia nigra.

Authors:  Jason Langley; Daniel E Huddleston; Xiangchuan Chen; Jan Sedlacik; Nishant Zachariah; Xiaoping Hu
Journal:  Neuroimage       Date:  2015-02-28       Impact factor: 6.556

Review 7.  Post-Mortem MRI and Histopathology in Neurologic Disease: A Translational Approach.

Authors:  Laura E Jonkman; Boyd Kenkhuis; Jeroen J G Geurts; Wilma D J van de Berg
Journal:  Neurosci Bull       Date:  2019-02-21       Impact factor: 5.203

8.  Relationship between neuromelanin and dopamine terminals within the Parkinson's nigrostriatal system.

Authors:  Antonio Martín-Bastida; Nicholas P Lao-Kaim; Andreas Antonios Roussakis; Graham E Searle; Yue Xing; Roger N Gunn; Stefan T Schwarz; Roger A Barker; Dorothee P Auer; Paola Piccini
Journal:  Brain       Date:  2019-07-01       Impact factor: 13.501

Review 9.  Role of Neuroimaging on Differentiation of Parkinson's Disease and Its Related Diseases.

Authors:  Toshihide Ogawa; Shinya Fujii; Keita Kuya; Shin-Ichiro Kitao; Yuki Shinohara; Mana Ishibashi; Yoshio Tanabe
Journal:  Yonago Acta Med       Date:  2018-09-26       Impact factor: 1.641

10.  Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisited.

Authors:  Jason Langley; Daniel E Huddleston; Michael Merritt; Xiangchuan Chen; Rebecca McMurray; Michael Silver; Stewart A Factor; Xiaoping Hu
Journal:  Hum Brain Mapp       Date:  2016-03-29       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.